|
gptkbp:instanceOf
|
gptkb:immune_response
|
|
gptkbp:administeredBy
|
pregnant women
Rh-negative individuals
|
|
gptkbp:alsoKnownAs
|
gptkb:Rho(D)_immune_globulin
|
|
gptkbp:approvedBy
|
gptkb:FDA
1968
|
|
gptkbp:ATCCode
|
gptkb:J06BB01
|
|
gptkbp:CASNumber
|
80723-08-6
|
|
gptkbp:category
|
gptkb:immunotherapy
gptkb:blood_product
gptkb:monoclonal_antibody
|
|
gptkbp:contraindication
|
hypersensitivity to immunoglobulins
|
|
gptkbp:discoveredIn
|
1960s
|
|
gptkbp:essentialMedicine
|
true
|
|
gptkbp:legalStatus
|
prescription only
|
|
gptkbp:marketedAs
|
gptkb:BayRho-D
gptkb:WinRho
RhoGAM
HyperRHO
Rhophylac
|
|
gptkbp:mechanismOfAction
|
binds to RhD antigen on red blood cells
|
|
gptkbp:pregnancyCategory
|
C (US)
|
|
gptkbp:prevention
|
hemolytic disease of the newborn
sensitization to RhD antigen
|
|
gptkbp:producedBy
|
human plasma
|
|
gptkbp:PubChem_CID
|
25077121
|
|
gptkbp:routeOfAdministration
|
intramuscular injection
intravenous injection
|
|
gptkbp:sideEffect
|
fever
headache
allergic reactions
injection site reactions
|
|
gptkbp:UNII
|
QX9KQ3FJ1L
|
|
gptkbp:usedFor
|
miscarriage
abortion
childbirth
amniocentesis
treatment of immune thrombocytopenic purpura
prevention of Rh disease
abdominal trauma during pregnancy
|
|
gptkbp:WHOModelListOfEssentialMedicines
|
true
|
|
gptkbp:bfsParent
|
gptkb:Rho(D)_immune_globulin
|
|
gptkbp:bfsLayer
|
8
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Anti-D immunoglobulin
|